Welltower Inc. $WELL Shares Sold by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. cut its holdings in shares of Welltower Inc. (NYSE:WELLFree Report) by 13.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 24,137 shares of the real estate investment trust’s stock after selling 3,860 shares during the period. Crossmark Global Holdings Inc.’s holdings in Welltower were worth $4,300,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its holdings in shares of Welltower by 4.7% in the third quarter. Vanguard Group Inc. now owns 89,778,383 shares of the real estate investment trust’s stock valued at $15,993,121,000 after acquiring an additional 3,991,896 shares in the last quarter. State Street Corp boosted its holdings in Welltower by 4.6% in the 2nd quarter. State Street Corp now owns 39,616,289 shares of the real estate investment trust’s stock valued at $6,090,212,000 after purchasing an additional 1,740,196 shares in the last quarter. Norges Bank acquired a new position in Welltower during the 2nd quarter worth approximately $4,903,554,000. Geode Capital Management LLC raised its stake in shares of Welltower by 5.1% during the 2nd quarter. Geode Capital Management LLC now owns 15,012,454 shares of the real estate investment trust’s stock worth $2,303,484,000 after buying an additional 723,887 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its stake in shares of Welltower by 1.9% during the 2nd quarter. JPMorgan Chase & Co. now owns 7,898,391 shares of the real estate investment trust’s stock worth $1,214,232,000 after buying an additional 149,724 shares in the last quarter. 94.80% of the stock is owned by hedge funds and other institutional investors.

Welltower Stock Performance

Shares of WELL opened at $204.09 on Friday. Welltower Inc. has a 1 year low of $130.29 and a 1 year high of $216.43. The company’s 50 day simple moving average is $195.27 and its 200 day simple moving average is $185.92. The company has a market capitalization of $142.40 billion, a price-to-earnings ratio of 145.78, a PEG ratio of 1.40 and a beta of 0.82. The company has a debt-to-equity ratio of 0.45, a quick ratio of 3.46 and a current ratio of 3.46.

Welltower (NYSE:WELLGet Free Report) last released its earnings results on Tuesday, February 10th. The real estate investment trust reported $1.45 EPS for the quarter, topping the consensus estimate of $1.44 by $0.01. The firm had revenue of $3.18 billion during the quarter, compared to analysts’ expectations of $2.93 billion. Welltower had a net margin of 8.64% and a return on equity of 2.46%. Welltower’s revenue for the quarter was up 41.3% on a year-over-year basis. During the same period in the previous year, the company earned $1.13 EPS. Welltower has set its FY 2026 guidance at 6.090-6.25 EPS. On average, sell-side analysts predict that Welltower Inc. will post 4.88 EPS for the current year.

Welltower Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Stockholders of record on Wednesday, February 25th will be given a $0.74 dividend. The ex-dividend date of this dividend is Wednesday, February 25th. This represents a $2.96 dividend on an annualized basis and a dividend yield of 1.5%. Welltower’s payout ratio is currently 211.43%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the company. Jefferies Financial Group restated a “buy” rating and issued a $231.00 price target on shares of Welltower in a research note on Monday, December 15th. Weiss Ratings cut Welltower from a “buy (b-)” rating to a “hold (c)” rating in a research report on Tuesday, February 17th. Cantor Fitzgerald raised their target price on Welltower from $204.00 to $230.00 and gave the company an “overweight” rating in a report on Thursday, February 12th. Morgan Stanley lifted their price objective on Welltower from $200.00 to $215.00 and gave the stock an “overweight” rating in a report on Wednesday, February 18th. Finally, Royal Bank Of Canada boosted their target price on Welltower from $207.00 to $230.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 24th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Welltower has a consensus rating of “Moderate Buy” and a consensus price target of $224.71.

Check Out Our Latest Report on WELL

Welltower Company Profile

(Free Report)

Welltower Inc (NYSE: WELL) is a real estate investment trust (REIT) that acquires and manages real estate serving the health care industry. The company specializes in healthcare infrastructure, owning and operating a diversified portfolio of senior housing, post-acute and long-term care communities, and outpatient medical properties. Welltower’s assets are designed to support the delivery of health care services through a combination of leased properties, joint ventures, and other capital arrangements with health care operators and providers.

The company’s property types include assisted living, memory care, independent living and skilled nursing facilities, as well as medical office buildings and other outpatient-care real estate such as ambulatory surgery centers and specialty clinics.

Read More

Institutional Ownership by Quarter for Welltower (NYSE:WELL)

Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.